Reserach Projects
Ariel Wang
MSc, PhD
Senior Statistician
I am a senior statistician in the hypertension team. My research interests include methodology studies, diagnostic studies, risk prediction models, big data, and trials (including RCTs). I work on the STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY) project, where we develop prediction models to understand an individual’s risk of specific adverse events associated with antihypertensive treatment, and the OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE) project, which investigates whether and to what extent blood pressure medications can be safely reduced in poly-antihypertensives-medicated older patients. Currently, I lead the SPCR-funded methodology study Agreement of data Generated from Routine Electronic hEalth records across primary and secondary care and a randomised controlled trial (AGREE), which aims to provide reliable evidence pertaining to data accuracy.
Before joining the PHC, I worked as a medical statistician in the Centre for Statistics in Medicine and Oxford Clinical Trial Research Unit in NDORMS. I contributed statistical expertise to the statistical analysis and reporting of trials across a range of clinical areas including diagnostic study, cancer, trauma, rehabilitation, surgical trials, as well as drug trials.
I hold a PhD in Health Sciences. My PhD research focused on the epidemiology of mental well-being in later life and explored various aspects of mental well-being, including its distribution, determinants, and consequences.
Recent publications
- 
                            
    
        
            
                Agreement and utility of coded primary and secondary care data for long-term follow-up of clinical trial outcomes
Journal article
Wang A. et al, (2025), BMC Medical Research Methodology, 25
 - 
                            
    
        
            
                Implementation, Processes and Outcomes of Advance Care Planning: A Culturally and Contextually Appropriate Programme Theory Developed in Chinese Long-Term Care Facilities
Journal article
Zhou Y. et al, (2025), Health Expectations, 28
 - 
                            
    
        
            
                Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations
Journal article
Wang A. et al, (2025), Journal of Hypertension
 - 
                            
    
        
            
                Risk Stratification in Older Intensively Treated Patients With AML
Journal article
Versluis J. et al, (2024), Journal of Clinical Oncology, 42, 4084 - 4094
 - 
                            
    
        
            
                Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Journal article
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573